| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0009 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |